Indication

Nosocomial pneumonia due to Haemophilus influenzae

Nosocomial pneumonia due to *Haemophilus influenzae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative coccobacillus *Haemophilus influenzae*, developing 48 hours or more after inpatient admission. Read more about Nosocomial pneumonia due to Haemophilus influenzae

65 drugs 52 manufacturers

Advertisement

Drugs that treat it

Common Nosocomial pneumonia due to Haemophilus influenzae therapies.

Showing 19–27 of 65 drugs

Filter & compare in the drug finder →Opens the drug finder with Nosocomial pneumonia due to Haemophilus influenzae preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Nosocomial pneumonia due to Haemophilus influenzae.

Nosocomial pneumonia due to *Haemophilus influenzae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative coccobacillus *Haemophilus influenzae*, developing 48 hours or more after inpatient admission.

It primarily affects hospitalized patients, particularly those undergoing mechanical ventilation, older adults, individuals with structural lung disease, or those with impaired airway clearance and consciousness.

Pathophysiologically, the condition arises when endogenous or aspirated organisms from the upper respiratory tract colonize the lower airways, triggering alveolar inflammation, exudate accumulation, and impaired gas exchange.

Clinically, it is defined by new or progressive pulmonary infiltrates on chest imaging accompanied by systemic and local signs of infection, such as fever, purulent sputum production, leukocytosis, and worsening respiratory failure.

Personalize your experience

Follow Nosocomial pneumonia due to Haemophilus influenzae and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it